Allopurinol Versus Febuxostat Use and the Risk of Cardiovascular Disease in People With Chronic Kidney Disease: A New-User Active Comparator Cohort Study. [PDF]
Inoue R +5 more
europepmc +1 more source
A Systemic Review and Network Meta-Analysis of Cardiovascular Safety of Benzbromarone, Febuxostat, and Allopurinol in Patients with Gout [PDF]
Ting Syuan Lin +6 more
openalex +1 more source
Febuxostat may decrease the incidence of COVID-19 infection among patients with gout: a retrospective cohort study. [PDF]
Wang W +5 more
europepmc +1 more source
Ameliorating Acute Kidney Injury Induced by Ischemia-Reperfusion by Targeting Purine Metabolism. [PDF]
Zhao L, Zhang T, Zhou X.
europepmc +1 more source
Gnetumgams A and B: two new 2-phenylbenzofuran derivatives from the lianas of <i>Gnetum montanum</i> with xanthine oxidase inhibitory activity. [PDF]
Van Do TN +4 more
europepmc +1 more source
Evaluation of febuxostat in treating diabetic kidney disease with hyperuricemia: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Lin M +5 more
europepmc +1 more source
Xanthine oxidase inhibitory and antioxidant potential of Indian Muscodor species [PDF]
Neha Kapoor, Sanjai Saxena
core +1 more source
Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis [PDF]
Sollip Kim +7 more
openalex +1 more source
Febuxostat Versus Allopurinol Use in Gout Patients: A Real-World Study. [PDF]
Voskamp J, Tausche AK.
europepmc +1 more source

